MannKind Corporation

MNKD ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $43.9M $22.9M $59.1M $120.8M $70.8M $61.8M $2.7M $66.1M
Accounts Receivable $2.8M $302.0K $23.0K $50.4M — — — —
Inventory $2.7M $2.3M — $9.7M — — — —
Total Current Assets $57.2M $77.5M $76.7M $201.2M $76.3M $66.8M $5.8M $74.0M
Property, Plant & Equipment $26.9M $28.9M $48.7M $192.1M $176.6M $184.0M $193.0M $202.4M
Goodwill — — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — — —
Total Assets $84.6M $107.1M $126.4M $394.4M $258.6M $251.3M $199.6M $277.3M
Liabilities
Accounts Payable $7.0M $3.3M $15.6M $7.4M $3.9M $4.6M $4.6M $3.3M
Total Current Liabilities $87.6M $92.1M $268.3M $403.4M $127.8M $144.8M $25.4M $18.1M
Long-Term Debt — — — — — — — —
Total Liabilities $299.3M $290.7M $476.7M $468.2M $289.4M $362.0M $513.2M $462.8M
Stockholders' Equity
Retained Earnings $-2.85B $-2.74B $-2.86B $-2.49B $-2.30B — — —
Total Stockholders' Equity $-214.7M $-183.6M $-350.3M $-73.8M $-30.7M $-110.7M $-313.7M $-185.5M
← Newer Page 2 of 2 Older →